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Abstract
Background: Plant sterols are an established non-pharmacological means to reduce total and LDL
blood cholesterol concentrations and are therefore recommended for cholesterol management by
worldwide-renown health care institutions. Their efficacy has been proven in many types of foods
with the majority of trials conducted in spreads or dairy products. As an alternative to dairy
products, soy based foods are common throughout the world. Yet, there is little evidence
supporting the efficacy of plant sterols in soy-based foods. The objective of this study was to
investigate the effect of a soy drink enriched with plant sterols on blood lipid profiles in moderately
hypercholesterolemic subjects.
Methods: In a randomized, placebo-controlled double-blind mono-centric study, 50 subjects were
assigned to 200 ml of soy drink either enriched with 2.6 g plant sterol esters (1.6 g/d free plant
sterol equivalents) or without plant sterols (control) for 8 weeks. Subjects were instructed to
maintain stable diet pattern and physical activity. Plasma concentrations of lipids were measured at
initial visit, after 4 weeks and after 8 weeks. The primary measurement was the change in LDL
cholesterol (LDL-C). Secondary measurements were changes in total cholesterol (TC), non-HDL
cholesterol (non-HDL-C), HDL cholesterol (HDL-C) and triglycerides.
Results: Regular consumption of the soy drink enriched with plant sterols for 8 weeks significantly
reduced LDL- C by 0.29 mmol/l or 7% compared to baseline (p < 0.05). TC and non-HDL-C
concentrations decreased by 0.26 mmol/l and 0.31 mmol/l (each p < 0.05), respectively. Mean
reductions in total, LDL and non-HDL cholesterol were significantly greater than in the placebo
group (p < 0.05). HDL-C and triglycerides were not affected. Compliance was very high (>96%),
and products were well tolerated.
Conclusion: Daily consumption of a plant sterol-enriched soy drink significantly decreased total,
non-HDL and LDL cholesterol and is therefore an interesting and convenient aid in managing mild
to moderate hypercholesterolemia.
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Elevated blood LDL-cholesterol (LDL-C) concentrations
are one of the major independent risk factors for cardio-
vascular diseases. Therapeutic lifestyle changes including
dietary interventions, in particular a reduction of satu-
rated fat and cholesterol, are established as first line ther-
apy to reduce LDL-C. Additionally, plant sterols are
recommended as a further dietary option to decrease LDL-
C [1]. A multitude of clinical trials has documented that
the daily consumption of 2 g plant sterols results in a LDL-
C reduction by about 10% [2] which is additive to the
cholesterol-lowering effect of a low-fat diet [3]. Plant ster-
ols are naturally occurring compounds found in plant
cells walls of several foods such as nuts, grains, vegetables
and seeds. Their chemical structure is similar to that of
cholesterol differing only in the presence of an additional
methyl or ethyl group at carbon C-24. Plant sterols func-
tion as cholesterol-lowering ingredients, primarily by
competing with cholesterol for solubilization into mixed
micelles, and thus reduce intestinal absorption of dietary
and biliary cholesterol [4].
Traditionally, plant sterols have been incorporated into
high-fat products such as spreads and margarines.
Recently, they have also been proven to be effective in
low-fat foods such as low-fat yoghurts [5,6], milk [7,8]
and yoghurt drinks [9,10]. However, only few studies
have been performed on non-milk-based beverages
[11,12] and, to the best we know, there is no published
trial investigating the effectiveness of plant sterols incor-
porated into a soy-based beverage.
Soy-based products may present an appropriate food
matrix for plant sterols since there is increasing evidence
for the cardiovascular benefits of soy. Epidemiological
data have indicated that Asian populations consuming
soy as a dietary staple have a lower risk for cardiovascular
diseases than those consuming a Western diet [13,14].
Moreover, some clinical trials investigating the effect of
soy protein as part of a low-fat diet displayed significant
LDL-C reductions [15]. Hence, in addition to already
available milk-based products enriched with plant sterols,
soy based foods with plant sterols may serve as another
good option for people with hypercholesterolemia since it
combines heart health benefits from both soy protein and
plant sterols.
The aim of the following study was to demonstrate the
cholesterol-lowering effect of 2.6 g/d of plant sterol esters
(1.6 g/d of free plant sterol equivalents) incorporated into




A total of 50 subjects (19 men, 31 women) aged between
19 and 65 years (mean 40.36 ± 13.47 years) with known
but untreated moderate hypercholesterolemia were ran-
domly assigned to two groups. One subject withdrew
from the study due to personal reasons after 4 weeks of
intervention. Baseline characteristics of the study subjects
were shown in Table 1. No significant differences were
detected between groups. The products were overall well
tolerated with no differences in reported adverse events
between the study arms. With regard to subjects' compli-
ance, the control and fortified soy drinks were consumed
in similar manner and according to the recommendation
(mean >96%).
Blood lipids
Serum lipid concentrations are presented in Table 2. At
week 4, a significant reduction of LDL-C by 0.32 mmol/l
or 7.15% compared to baseline (p < 0.01) was observed
in the plant sterol group. At week 8, LDL-C was decreased
by 0.29 mmol/l corresponding to a relative reduction of
6.76% (p < 0.01). Total cholesterol was diminished by
0.32 mmol/l (p < 0.01) and 0.26 mmol/l (p < 0.01) from
baseline at week 4 and 8, respectively. In addition, non-
HDL-cholesterol was reduced by 0.35 mmol/l (p < 0.01)
and 0.31 mmol/l (<0.01). HDL-C and triglycerides were
not affected. The control group did not show any signifi-
cant modifications of the blood lipid profile over the
course of the treatment period. Comparing the percentage
changes of blood lipids after 8 weeks between verum and
placebo group, a significant difference was observed for
total (p < 0.05), LDL (p < 0.05), and non-HDL-C (p <
Table 1: Characteristics of the subjects at baseline1
Variable Control soy drink (n = 25) Soy drink enriched with plant sterols (n = 25) p
BMI (kg/m2) 23.94 ± 3.45 24.32 ± 3.10 0.2935
Systolic blood pressure(mmHg) 122.84 ± 10.64 120.76 ± 10.97 0.3591
Diastolic blood pressure(mmHg) 75.12 ± 8.09 78.04 ± 7.81 0.1699
Total cholesterol (mmol/l) 6.24 ± 0.77 6.42 ± 0.68 0.1429
Non-HDL-C (mmol/l) 4.67 ± 0.20 4.81 ± 0.57 0.2020
LDL-C (mmol/l) 4.10 ± 0.64 4.21 ± 0.52 0.1343
HDL-C (mmol/l) 1.57 ± 0.33 1.61 ± 0.38 0.3891
1 All values are means ± SDPage 2 of 8
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in any other laboratory values.
Satisfaction questionnaire
With regard to product satisfaction, estimated by the vol-
unteers completing questionnaires at the end of the study,
no difference was apparent between the control product
and the plant sterol enriched product. The taste was
deemed to be acceptable (data not shown) and a tendency
to consume this type of product preferably in the morning
was confirmed (Table 3). As to the habitual consumption,
24% of the verum group and 8% of the control group
stated to customary consume anti-cholesterol products,
whereas the 76% and 92%, respectively did not regularly
use cholesterol-lowering products.
Discussion
Dietary intervention is the cornerstone of non-pharmaco-
logical strategies to reduce LDL-C and thereby improving
cardiovascular health. Regular consumption of plant
sterol-enriched foods and an increase in dietary fiber
intake are recommended to enhance the cholesterol-low-
ering dietary modifications [1]. In the present controlled,
double-blind trial, a significant reduction in total, non-
HDL- and LDL-cholesterol was observed after daily con-
sumption of a plant sterol-enriched soy beverage. The
magnitude of the LDL-C reduction in this trial (7%) is in
accordance with previous reported studies in which LDL-
C was decreased by at least 5% compared to control. For
instance, in adults with mild hypercholesterolemia, con-
sumption of plant sterols provided as spreads reduced
LDL-C by 5.4% [16]. The intake of plant sterol-enriched
Table 2: Serum lipid concentrations at baseline and at week 4 and week 81
Control soy drink Soy drink enriched with plant sterols
Total cholesterol (mmol/l)
Baseline (V0) 6.24 ± 0.77 6.42 ± 0.68
Week 4 (V2) 6.12 ± 0.64 6.10 ± 0.64a
Week 8 (V3) 6.16 ± 0.79 6.16 ± 0.79a
Change (%) between V2 and V0 -1.34 -4.76
Change (%) between V3 and V0 -1.05 -3.91b
LDL-cholesterol (mmol/l)
Baseline (V0) 4.10 ± 0.64 4.21 ± 0.64
Week 4 (V2) 4.00 ± 0.74 3.89 ± 0.44a
Week 8 (V3) 4.09 ± 0.73 3.92 ± 0.61a
Change (%) between V2 and V0 -1.91 -7.15
Change (%) between V3 and V0 +0.84 -6.76b
Non-HDL-cholesterol (mmol/l)
Baseline (V0) 4.67 ± 0.70 4.81 ± 0.57
Week 4 (V2) 4.58 ± 0.76 4.46 ± 0.56a
Week 8 (V3) 4.61 ± 0.78 4.50 ± 0.76a
Change (%) between V2 and V0 -1.31 -6.95b
Change (%) between V3 and V0 -0.22 -6.38b
HDL-cholesterol (mmol/l)
Baseline (V0) 1.57 ± 0.33 1.61 ± 0.38
Week 4 (V2) 1.55 ± 0.35 1.64 ± 0.44
Week 8 (V3) 1.53 ± 0.35 1.66 ± 0.45
Change (%) between V2 and V0 -0.52 +1.92
Change (%) between V3 and V0 -1.69 +3.07
Triglyceride (mmol/l)
Baseline (V0) 1.23 ± 1.29 1.29 ± 0.48
Week 4 (V2) 1.25 ± 0.73 1.24 ± 0.57
Week 8 (V3) 1.12 ± 0.49 1.27 ± 0.62
Change (%) between V2 and V0 +0.76 -2.33
Change (%) between V3 and V0 -5.35 +0.09
1 All values are mean ± SD.
a significant compared to baseline, p < 0.05.
b significant compared to control, p < 0.05.Page 3 of 8
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[17] and 6%, respectively [18].
Traditionally, high-fat products such as spreads were cho-
sen as food matrix for plant sterols due to the fat-soluble
nature of plant sterol esters. A meta-analysis of rand-
omized, placebo-controlled trials using fatty food matrix
enriched with sterols reported mean LDL-C reductions
ranging from 6.7% to 11.3% according to dose [2]. More
recent research has focussed on the cholesterol-lowering
effects of plant sterol-enriched low-fat foods, such as
yoghurts, yoghurt drinks, milk and orange juice. As indi-
viduals with elevated LDL-C concentrations are advised to
limit their dietary saturated fat intake, these products may
be of particular interest for the management of hypercho-
lesterolemia. Soy products such as the soy drink used in
this trial are known to be low in saturated fat and might
therefore be an appropriate matrix for plant sterols as
well.
However, the effects of plant sterol-enriched low-fat foods
on cholesterols are inconsistent in published studies. One
study, such as Jones et al. [19], failed to show a significant
improvement of the blood lipid profile after intake of
plant sterols provided as low-fat and non-fat beverages
compared to control, whereas other studies reported that
plant sterols were effective in reducing LDL-C when incor-
porated into low-fat or non-fat foods [1,5,11,17,20] or
even when provided as capsules [21,22]. The degree of
solubilization and dispersion of plant sterols as well as the
intake occasion appears to account in part for the variable
results [23]. Doornbos et al. [9] demonstrated that a low-
fat single dose drink significantly lowered LDL-C both
when taken with or without a meal. However, a substan-
tially larger decrease in blood cholesterol concentrations
was achieved when a single-dose drink was consumed
with or directly after lunch (-9.3% vs. – 5.1%, p < 0.005).
As plant sterols reduce the intestinal cholesterol absorp-
tion by competing with cholesterol for micellar solubili-
Blood lipid changes (mean in % ± SE) between baseline (V0) and week 8 (V3)Figure 1
Blood lipid changes (mean in % ± SE) between baseline (V0) and week 8 (V3). TC: Total cholesterol, Non-HDL-C: 
Non-HDL cholesterol, LDL-C: LDL cholesterol, p for inter group variation, *p < 0.05 vs. control.
Table 3: Satisfaction questionnaire: When would you consume the product? Multiple answers possible
% responses Control soy drink Soy drink enriched with plant sterols
At breakfast 67 64
As a snack during the morning 56 54
During the meal (lunch or dinner) 4 8
During the afternoon 8 17
As a snack during the afternoon 20 25
In the evening, after dinner 0 4
Just before going to bed 4 0
Don't know 4 4Page 4 of 8
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gastrointestinal transit time and stimulating bile flow may
influence the cholesterol-lowering efficacy of plant ster-
ols. The soy juice consumed in this study was taken with
breakfast or during the morning. As the breakfast was not
standardized and the majority of participants had a rather
small than a comprehensive breakfast according to French
consumption habits, it cannot be ruled out that these
aspects had an impact on the cholesterol-lowering efficacy
of the plant sterol-enriched soy drink. Thus, the intake of
the soy drink with lunch or dinner might have resulted in
greater cholesterol-lowering effects.
Plant sterols are recommended in addition to dietary
changes for successful non-pharmacological intervention
of elevated cholesterol. Moreover, the American Heart
Association proposes the inclusion of at least 25 g/d of soy
protein in a low fat, low cholesterol diet to reduce the risk
of coronary heart disease. Clinical trials have reported that
a daily consumption of 25–50 g/d of soy protein decreases
LDL-C by about 4 to 8% [24], for instance. While plant
sterols reduce the intestinal absorption of cholesterol, soy
protein is thought to lower blood cholesterol concentra-
tions via a decrease in hepatic cholesterol synthesis [25] or
through an increase of plasma cholesterol clearance [26].
Therefore, it may be possible that a combination of these
natural ingredients has additive effects and may therefore
modify the blood lipid profile more favourably than a sin-
gle ingredient. However, very few studies have investi-
gated a possible synergistic effect yet [27-29].
In the present study, the control soy drink did not signifi-
cantly affect blood lipids over 8 week period, which could
be due to the low soy protein content (7 g/d). In contrast,
the soy drink enriched with plant sterols significantly
decreased LDL-C by 7% suggesting a beneficial effect from
plant sterols.
Albeit low-dose soy protein products alone may not allow
individuals with elevated cholesterol levels to achieve
there lipid targets, they are nonetheless a meaningful
matrix for the incorporation of plant sterols, since soy
products do not unbalance the daily energy intake or
modify the pattern of dietary habits. The latter aspect may
be important to obtain a good patient compliance during
long-term intervention [27]. Moreover, the substitution of
soy for animal protein can result in lower saturated fat and
cholesterol intakes, thereby indirectly leading to a more
favourable blood cholesterol level and potentially reduc-
ing the risk of coronary heart disease [30].
As to the satisfaction of volunteers with the product taste,
no difference was observed between treatment and con-
trol beverage indicating a proper introduction of the plant
sterols into the soy drink. The majority of subjects pre-
ferred to consume of the cholesterol-lowering drink at
breakfast or as a snack during the morning or afternoon.
Since studies have shown plant sterols to be more effective
when consumed in combination with a (main) meal [9],
consumption recommendations on the package of the
product may be helpful to ensure a maximum effect for
the consumers. The fact that a large part of subjects did no
habitually consume anti-cholesterol products such as
plant sterols suggests that people having elevated choles-
terol levels are often not familiar with or not aware of such
cholesterol-lowering options. Consequently, intensified
public information about non-pharmacological interven-
tions for cholesterol management is desirable and may
help to reduce the high prevalence of hypercholestero-
lemia.
Conclusion
A soy drink enriched with plant sterols is effective in low-
ering total and LDL cholesterol in subjects with moderate
hypercholesterolemia. Therefore, it may be used as
another potential dietary approach to the management of
hypercholesterolemia. A replacement of animal-based
products by soy-based product may further contribute to
a reduction of blood cholesterol levels. Moreover, soy pro-
tein is proposed to have hypocholesterolemic properties
itself. Whether the effects of plant sterols and soy protein
are synergistic remains to be further investigated in future
clinical trials.
Methods
The study was performed according to Good Clinical Prac-
tice (GCP) at Biofortis, Nantes, France and was approved
by the Ethics Committee of the Comité de Protection des
Personnes se Prêtant à la Recherche Biomedicale (CCP-
PRB) des Pays de la Loire, Nantes, France. Subjects were
recruited via newspaper advertisement or have been
selected from the volunteers' base of the study center.
Subjects
Subjects with known but untreated moderate hypercho-
lesterolemia were screened on the basis of following
inclusion criteria: LDL-C 130–220 mg/dl depending on
other cardiovascular risk factors present (as to the AFSS-
APS criteria, the inclusion LDL-C limit for subjects with-
out any other risk factors was 220 mg/dl, for subjects with
one additional risk factor 190 mg/dl, and for those with
two additional risk factors 160 mg/dl); body mass index ≤
30 kg/m2 triglyceride concentrations < 200 mg/dl; no
severe disease necessitating pharmacological interven-
tion; no hepatic disease, gastrointestinal complaints, no
thyroid dysfunction or any kidney disease; no personal
history of cardiovascular illness; no diabetes; no hyperten-
sion in terms of the WHO criteria (140/90 mmHg) and no
known food allergy.Page 5 of 8
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The study was a mono-centric, randomized, double blind,
placebo-controlled trial in parallel groups of 25 subjects
each. All subjects gave informed consent. The study was
conducted over a 10-week period including a 2-week run-
in phase (general dietary recommendations, exclusion of
plant sterol enriched foods) and 8 weeks of intervention
(Figure 2). After run-in, subjects were randomized to
either 200 ml soy drink without plant sterols (control) or
200 ml soy drink enriched with plant sterols (Vegapure
95E®, Cognis GmbH, Monheim, Germany). The soy bev-
erages were consumed either with breakfast or during the
morning before noon. Participants were encouraged to
continue with their normal diet and exercise pattern dur-
ing the study period.
Clinical examination was performed at selection (visit 0,
V0), inclusion (V1), follow-up (V2, week 4) and end of
intervention (V3, week 8). Blood samples were taken at
V0, V2, and V3, dietary and lifestyle advice was given at
V0, V1, and V2. A food survey was performed at V1 and
V3. The compliance with the product was established by
counting the empty packages on V2 and V3. Adverse
events were reported by the volunteers by filling in a ques-
tionnaire at V1, V2, and V3. During visit V3, the volun-
teers filled in a questionnaire regarding the overall
satisfaction with the product.
Products
The control product was 200 ml of soy drink (Nutrition &
Santé, Revel, France) without plant sterols. The test prod-
uct was the same soy drink enriched with 2.6 g/d plant
sterol esters (1.6 g/d of free plant sterol equivalents,
Study programFigure 2
Study program.Page 6 of 8
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the product formulation and composition of plant sterols
see Tables 4 and 5.
Outcomes
The primary outcome was LDL cholesterol. Secondary
outcomes were total cholesterol, non-HDL cholesterol,
HDL cholesterol and triglycerides. Blood samples were
taken after a 12-h overnight fast. LDL cholesterol calcula-
tion was performed using Friedewald equation.
Additionally, the individual feedback with regard to prod-
uct taste and consumption habits was documented.
Statistical analysis
SAS software version 8.2 was used for the statistical analy-
sis. The main effective criterion was the change in the con-
centration of serum LDL-cholesterol (LDL-C). The study
was designed to detect a difference in LDL-C by 8%
between groups with an alpha risk of 0.05, and a beta risk
of 0.01 or 0.02. The effect of the treatment was evaluated
by non-parametric Wilcoxon test which compared the
data obtained after four and eight weeks of treatment in
the group receiving the control soy drink with those
obtained in the group receiving plant sterol enriched soy
drink. The same analysis was performed for comparisons
of intra-group changes (V0 vs. V2, V0 vs. V3). The analysis
was conducted according to "intention to treat" popula-
tion comprising all the subjects included in the study. For
the subject leaving the study prematurely, a blood sample
was taken at time of his premature departure.
The discontinuous data of the satisfaction questionnaire
were analyzed by means of a chi2 test and the questions to
which a mark was attached were analyzed by a Wilcoxon
test, after calculating the mean values obtained from each
group.
List of abbreviations
AFSSAPS: Agence Française de Securite Sanitaire des Pro-
duits de Sante; CCPPRB: Comité de Protection des Per-
sonnes se Prêtant à la Recherche Biomedicale; d: day; g:
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Table 4: Macronutrient composition of the soy drink products used in the study
Average content of 100 ml soy drink Control soy drink Soy drink enriched with plant sterols
Calories (kcal) 51.1 65
Energy (kj) 214.3 271
Protein (g) 3.5 3.6
Carbohydrates (g) 4.1 4.3
Of which sugars 2.3 3.3
Fat (g) 2.3 3.7
Of which free sterol 0 0.8
Fibres (g) 0.47 0.49
Sodium (g) 0.1 0.1
Table 5: Sterol composition of Vegapure 95E®
Sterol composition (as free sterols) By GC, rel. area (%), typical values (max.*)
Beta-Sitosterol 69.1% (max. 80%)
Beta-Sitostanol 7.9% (max.15%)
Campesterol 15.3% (max. 40%)
Campestanol 1.0% (max. 5%)
Stigmasterol 0.8% (max. 30%)
Brassicasterol 2.8% (max. 3%)
Other sterols/stanols 2.7% (max. 3%)
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